Clinical Trial Update: Stool Transplants to Treat Refractory Clostridium Difficile Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using stool/fecal microbiota transplantation to treat refractory Clostridioides difficile infection; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Duke University | Conditions: Clostridium Difficile Colitis | Phase 2 | Status: RECRUITING